Merus N.V. | Key People and Executives
Mark T. Iwicki
Chairman-Supervisory Board
Ton Logtenberg
Chief Executive Officer & Executive Director
Wolfgang Berthold
Member-Supervisory Board
Gregory D. Perry
Member-Supervisory Board
Anand Mehra
Member-Supervisory Board
John de Koning
Member-Supervisory Board
Lionel Carnot
Member-Supervisory Board
Mark T. Iwicki
Chairman-Supervisory Board
Ton Logtenberg
Chief Executive Officer & Executive Director
John J. Crowley
Chief Financial Officer & Executive Vice President
L. Andres Sirulnik
Chief Medical Officer & Executive Vice President
Mark Throsby
Chief Scientific Officer & Executive VP
John de Kruif
Chief Technology Officer & Senior Vice President
Liu Hui
Chief Business Officer & Executive Vice President
Lex Bakker
Chief Development Officer
Wolfgang Berthold
Member-Supervisory Board
Gregory D. Perry
Member-Supervisory Board
Anand Mehra
Member-Supervisory Board
Peter B. Silverman
General Counsel
John Paul de Koning
Member-Supervisory Board
Lionel Carnot
Member-Supervisory Board
| Address |
Yalelaan 62
Utrecht Utrecht 3584 CH
Netherlands
|
|
Employees
|
- |
| Website |
http://www.merus.nl |
| Updated |
07/08/2019 |
| Merus NV is a clinical-stage immune-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg on June 16, 2003 and is headquartered in Utrecht, Netherlands. |
